Laboratory for Axon Growth and Regeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn 53127, Germany
J Neurosci. 2022 Nov 9;42(45):8393-8405. doi: 10.1523/JNEUROSCI.1131-22.2022.
Axons differ in their growth potential: whereas during development, axons rapidly grow to their targets, in the adult mammalian, CNS axons have lost their ability to grow and therefore fail to regenerate. Recent progress has enabled a better understanding of how developmental mechanisms direct axon regeneration. Focusing on neuronal polarization, where one neurite is singled out to become the axon, has uncovered the mechanisms initiating axon growth and growth restraint. This has helped to define the processes that need to be reactivated to induce axon regeneration: microtubule stabilization and actin dynamics. The molecular machinery underlying axon growth and axon regeneration is remarkably similar and includes the Rho-GTPases Cdc42, Rac-1, and RhoA, as well as the actin regulators cofilin and Myosin II. Importantly, neuron-intrinsic growth inhibitors in the adult nervous system, including the voltage-gated calcium channel subunit α2δ2 and the presynaptic active zone protein Munc13, restrain dynamics while the components driving axon growth remain largely present. The identified molecules suggest that synaptic transmission and axon growth may be processes that exclude each other. As a result, axon regeneration may be hampered by synaptic transmission and, thus, by the maturation of the CNS. This research has led to several translational avenues to induce axon regeneration and functional recovery after spinal cord injury and stroke; these include the drugs epothilones, gabapentinoids, and baclofen. Thus, the investigation of axon growth and regeneration side by side has been instrumental to coax the regenerative potential of the CNS.
在发育过程中,轴突迅速生长到其靶标,但在成年哺乳动物的中枢神经系统中,轴突已经失去了生长的能力,因此无法再生。最近的进展使我们更好地理解了发育机制如何指导轴突再生。关注神经元极化,即一个轴突被挑选出来成为轴突,揭示了启动轴突生长和生长抑制的机制。这有助于确定需要重新激活哪些过程来诱导轴突再生:微管稳定和肌动蛋白动力学。轴突生长和轴突再生的分子机制非常相似,包括 Rho-GTPases Cdc42、Rac-1 和 RhoA,以及肌动蛋白调节因子丝切蛋白和肌球蛋白 II。重要的是,成年神经系统中的神经元内在生长抑制剂,包括电压门控钙通道亚基α2δ2 和突触前活性区蛋白 Munc13,在驱动轴突生长的成分基本存在的情况下,限制了动力学。鉴定出的分子表明,突触传递和轴突生长可能是相互排斥的过程。因此,轴突再生可能会受到突触传递的阻碍,从而受到中枢神经系统成熟的阻碍。这项研究导致了几种诱导脊髓损伤和中风后轴突再生和功能恢复的转化途径;这些药物包括埃坡霉素、加巴喷丁类药物和巴氯芬。因此,同时研究轴突生长和再生对于激发中枢神经系统的再生潜力至关重要。